PAVmed (PAVM) Revenue & Revenue Breakdown
PAVmed Revenue Highlights
Latest Revenue (Y)
$2.45B
Latest Revenue (Q)
$979.00M
Main Segment (Y)
Royalty
PAVmed Revenue by Period
PAVmed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.45B | 650297.88% |
| 2022-12-31 | $377.00K | -24.60% |
| 2021-12-31 | $500.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
PAVmed generated $2.45B in revenue during NA 2023, up 650297.88% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
PAVmed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $979.00M | 96830.69% |
| 2024-03-31 | $1.01M | -3.72% |
| 2023-12-31 | $1.05M | 32.62% |
| 2023-09-30 | $791.00K | 376.51% |
| 2023-06-30 | $166.00K | -62.78% |
| 2023-03-31 | $446.00K | 298.21% |
| 2022-12-31 | $112.00K | 47.37% |
| 2022-09-30 | $76.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $189.00K | -37.00% |
| 2021-12-31 | $300.00K | 50.00% |
| 2021-09-30 | $200.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | - |
PAVmed generated $979.00M in revenue during Q2 2024, up 96830.69% compared to the previous quarter, and up 219506.73% compared to the same period a year ago.
PAVmed Revenue Breakdown
PAVmed Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Royalty | $100.00M | $100.00M |
PAVmed's latest annual revenue breakdown by segment (product or service), as of Dec 22: Royalty (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 22 | Mar 22 |
|---|---|---|
| Royalty | - | $100.00M |
| Minimum Annual Royalty Fee | - | $100.00M |
PAVmed Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 22 |
|---|---|
| Minimum Annual Royalty Fee | $100.00M |
| Royalty | $100.00M |
PAVmed's latest quarterly revenue breakdown by geography, as of Mar 22: Minimum Annual Royalty Fee (50.00%), and Royalty (50.00%).
PAVmed Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAVM | PAVmed | $2.45B | $979.00M |
| NARI | Inari Medical | $493.63M | $145.82M |
| TMDX | TransMedics Group | $241.62M | $114.31M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| TELA | TELA Bio | $58.45M | $16.09M |
| MXCT | MaxCyte | $41.29M | $11.34M |
| CVRX | CVRx | $39.30M | $11.81M |
| OSA | ProSomnus | $27.65M | $7.46M |
| CLPT | ClearPoint Neuro | $23.95M | $7.86M |
| HYPR | Hyperfine | $11.03M | $3.63M |
| DCTH | Delcath Systems | $2.06M | $7.77M |
PAVM Revenue FAQ
What is PAVmed’s yearly revenue?
PAVmed's yearly revenue for 2023 was $2.45B, representing an increase of 650297.88% compared to 2022. The company's yearly revenue for 2022 was $377K, representing a decrease of -24.60% compared to 2021. PAVM's yearly revenue for 2021 was $500K, representing an increase of 100.00% compared to 2020.
What is PAVmed’s quarterly revenue?
PAVmed's quarterly revenue for Q2 2024 was $979M, a 96830.69% increase from the previous quarter (Q1 2024), and a 589659.04% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.01M, a -3.72% decrease from the previous quarter (Q4 2023), and a 126.46% increase year-over-year (Q1 2023). PAVM's quarterly revenue for Q4 2023 was $1.05M, a 32.62% increase from the previous quarter (Q3 2023), and a 836.61% increase year-over-year (Q4 2022).
What is PAVmed’s revenue growth rate?
PAVmed's revenue growth rate for the last 3 years (2021-2023) was 490300.00%, and for the last 5 years (2019-2023) was 0%.
What are PAVmed’s revenue streams?
PAVmed's revenue streams in c 22 are Royalty
What is PAVmed’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of PAVmed was Royalty. This segment made a revenue of $100M, representing 100.00% of the company's total revenue.